Logo

Dutch Firm DSM Licenses Genomatica s Modeling Platform; Firms to Develop Model for Production Organism

Apr 19, 2005

NEW YORK, April 19 (GenomeWeb News) - Genomatica has signed a software licensing and development deal with DSM, a Dutch chemical and biotechnology firm, the company said today.

 

Under the agreement, DSM will license SimPheny, Genomatica's modeling and simulation platform, to use for strain engineering, process development, and other research areas. In addition, the two companies will jointly develop a metabolic model of production organism for SimpPheny.

 

San Diego-based Genomatica will receive undisclosed licensing fees and milestone payments.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.